Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	856	521	523	542	601	730
Market Cap Growth	74.10%	-0.23%	-3.62%	-9.76%	-17.67%	100.53%
Enterprise Value	846	520	523	552	595	710
Last Close Price	89.40	53.47	52.59	53.64	58.34	69.83
PE Ratio	40.62	26.07	31.47	42.26	39.94	53.01
Forward PE	34.69	23.47	25.25	32.36	38.79	53.54
PS Ratio	6.17	3.95	4.50	5.39	7.24	10.71
PB Ratio	11.49	7.32	8.41	9.97	11.80	16.19
P/TBV Ratio	17.18	10.46	12.79	16.38	19.87	18.30
P/FCF Ratio	53.27	31.74	32.32	-	-	47.32
P/OCF Ratio	44.01	26.66	25.59	44.85	34.41	35.76
PEG Ratio	-	1.77	1.77	1.77	1.77	1.77
EV/Sales Ratio	6.10	3.94	4.50	5.49	7.16	10.41
EV/EBITDA Ratio	25.20	16.36	16.93	21.72	24.56	36.76
EV/EBIT Ratio	27.94	17.88	19.11	24.00	25.78	38.78
EV/FCF Ratio	52.66	31.68	32.33	-	-	46.00
Debt / Equity Ratio	0.26	0.29	0.39	0.52	0.35	0.14
Debt / EBITDA Ratio	0.57	0.64	0.79	1.10	0.73	0.33
Debt / FCF Ratio	1.19	1.25	1.50	-	-	0.41
Net Debt / Equity Ratio	-0.13	-0.14	-0.08	0.05	-0.18	-0.61
Net Debt / EBITDA Ratio	-0.30	-0.32	-0.15	0.11	-0.38	-1.43
Net Debt / FCF Ratio	-0.62	-0.61	-0.29	-2.50	1.05	-1.79
Asset Turnover	1.10	1.09	1.01	0.95	0.97	1.11
Inventory Turnover	8.04	8.28	7.53	7.76	10.13	15.13
Quick Ratio	2.11	1.86	1.94	1.70	1.96	3.08
Current Ratio	2.38	2.35	2.38	2.12	2.28	3.32
Return on Equity (ROE)	30.15%	29.87%	28.40%	24.36%	31.34%	33.26%
Return on Assets (ROA)	15.05%	14.99%	14.88%	13.54%	16.82%	18.58%
Return on Invested Capital (ROIC)	32.14%	32.39%	29.06%	25.63%	50.00%	74.25%
Return on Capital Employed (ROCE)	31.30%	30.90%	30.40%	27.20%	31.00%	33.50%
Earnings Yield	2.46%	3.84%	3.18%	2.37%	2.50%	1.89%
FCF Yield	1.88%	3.15%	3.09%	-0.21%	-1.45%	2.11%
Dividend Yield	1.39%	2.24%	1.90%	1.58%	1.37%	1.02%
Payout Ratio	45.62%	47.95%	49.20%	60.11%	45.53%	47.10%
Buyback Yield / Dilution	0.60%	0.16%	0.67%	0.05%	0.09%	-
Total Shareholder Return	2.01%	2.41%	2.57%	1.63%	1.46%	1.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.